UY25288A1 - Nuevos uretanos, sus análogos tio y ditio, sus sales, medicamentos que contienen estos compuestos y su empleo así como procedimientos para su preparación. - Google Patents

Nuevos uretanos, sus análogos tio y ditio, sus sales, medicamentos que contienen estos compuestos y su empleo así como procedimientos para su preparación.

Info

Publication number
UY25288A1
UY25288A1 UY25288A UY25288A UY25288A1 UY 25288 A1 UY25288 A1 UY 25288A1 UY 25288 A UY25288 A UY 25288A UY 25288 A UY25288 A UY 25288A UY 25288 A1 UY25288 A1 UY 25288A1
Authority
UY
Uruguay
Prior art keywords
salts
procedures
compounds
preparation
ditium
Prior art date
Application number
UY25288A
Other languages
English (en)
Inventor
Rolandd Maier
Peter Mueller
Gebhard Adelgoss
Gebhard Schilcher
Rudolf Hurnaus
Michael Mark
Bernhard Eisele
Original Assignee
Boehringer Ingelheim Pharma
Amp
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma, Amp, Co Kg filed Critical Boehringer Ingelheim Pharma
Publication of UY25288A1 publication Critical patent/UY25288A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/56—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02—Monothiocarbamic acids; Derivatives thereof
    • C07C333/06—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/14—Dithiocarbamic acids; Derivatives thereof
    • C07C333/18—Esters of dithiocarbamic acids
    • C07C333/24—Esters of dithiocarbamic acids having nitrogen atoms of dithiocarbamate groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Se refiere a uretanos así como a sus análogos tio y ditio de la fórmula general (i); en la que m, n, A, X, Y, y R1 a R8 están definidos como en la reivindicación 1, a sus enantiómeros, diastereoisómeros y sus sales, en particular sus sales por adición de ácidos fisiológicamente compatibles, que presentan valiosas propiedades, en particular un efecto inhibidor sobre la biosíntesis del colesterol, a medicamentos que contienen estos compuestos, a su empleo y a procedimientos para su preparación.
UY25288A 1997-12-10 1998-12-07 Nuevos uretanos, sus análogos tio y ditio, sus sales, medicamentos que contienen estos compuestos y su empleo así como procedimientos para su preparación. UY25288A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19754795A DE19754795A1 (de) 1997-12-10 1997-12-10 Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
UY25288A1 true UY25288A1 (es) 2000-12-29

Family

ID=7851380

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25288A UY25288A1 (es) 1997-12-10 1998-12-07 Nuevos uretanos, sus análogos tio y ditio, sus sales, medicamentos que contienen estos compuestos y su empleo así como procedimientos para su preparación.

Country Status (30)

Country Link
US (1) US6346545B1 (es)
EP (1) EP1045832B1 (es)
JP (1) JP4001317B2 (es)
KR (1) KR20010024708A (es)
CN (1) CN1281431A (es)
AR (1) AR014405A1 (es)
AT (1) ATE291570T1 (es)
AU (1) AU747173B2 (es)
BG (1) BG104501A (es)
BR (1) BR9813545A (es)
CA (1) CA2310055C (es)
CO (1) CO5290251A1 (es)
CZ (1) CZ20002150A3 (es)
DE (2) DE19754795A1 (es)
EA (1) EA003298B1 (es)
EE (1) EE200000340A (es)
HR (1) HRP980621A2 (es)
HU (1) HUP0100292A3 (es)
ID (1) ID21432A (es)
IL (1) IL135737A0 (es)
NO (1) NO20002968L (es)
NZ (1) NZ505594A (es)
PE (1) PE133599A1 (es)
PL (1) PL341654A1 (es)
SK (1) SK8602000A3 (es)
TR (1) TR200001636T2 (es)
UY (1) UY25288A1 (es)
WO (1) WO1999029662A2 (es)
YU (1) YU35500A (es)
ZA (1) ZA9811263B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2715310A1 (en) * 2008-02-22 2009-08-27 Basf Se Fungicidal compositions comprising 3'-bromine-2,3,4,6'-tetramethoxy-2'-6-dimethylbenzophenone
EP2658544A4 (en) * 2010-12-27 2014-05-28 Univ Missouri OXIDOSQUALENZYCASE AS A PROTEINT ARGET FOR ANTICIPATED THERAPEUTICS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2025490C (en) * 1989-09-22 2003-09-16 James R. Mccarthy Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
US5011859A (en) * 1990-03-30 1991-04-30 Merrell Dow Pharmaceuticals Inc. Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
CA2047375C (en) * 1990-07-25 2003-04-15 Charlotte L. Barney Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
US5084461A (en) * 1991-03-27 1992-01-28 Merrell Dow Pharmaceuticals Inc. Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis
US5466687A (en) 1992-10-22 1995-11-14 Dr. Karl Thomae Gmbh Arylidene-1-azacycloalkanes and arylalkyl-1-azacyclo-alkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
DE4303840A1 (de) * 1992-10-22 1994-08-11 Thomae Gmbh Dr K Aryliden-1-azacycloalkane und Arylalkyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4239150A1 (de) * 1992-11-20 1994-05-26 Thomae Gmbh Dr K O-Acyl-4-phenyl-cyclohexanole, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4239151A1 (de) 1992-11-20 1994-05-26 Thomae Gmbh Dr K N,N-Disubstituierte Arylcycloalkylamine, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4438020A1 (de) * 1994-10-25 1996-05-02 Thomae Gmbh Dr K N-substituierte Arylcyclohexylacylamine, ihre Salze mit physiologisch verträglichen organischen oder anorganischen Säuren, Verfahren zur Herstellung dieser Verbindungen und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
IL135737A0 (en) 2001-05-20
PL341654A1 (en) 2001-04-23
ZA9811263B (en) 2000-06-09
CN1281431A (zh) 2001-01-24
WO1999029662A3 (de) 1999-08-19
NO20002968L (no) 2000-08-09
JP4001317B2 (ja) 2007-10-31
EE200000340A (et) 2001-08-15
HRP980621A2 (en) 1999-08-31
JP2001525393A (ja) 2001-12-11
DE59812686D1 (de) 2005-04-28
TR200001636T2 (tr) 2001-08-21
EP1045832A2 (de) 2000-10-25
CA2310055A1 (en) 1999-06-17
HUP0100292A3 (en) 2002-11-28
ID21432A (id) 1999-06-10
EA003298B1 (ru) 2003-04-24
US6346545B1 (en) 2002-02-12
ATE291570T1 (de) 2005-04-15
CA2310055C (en) 2008-09-23
YU35500A (sh) 2002-09-19
AU1759399A (en) 1999-06-28
AR014405A1 (es) 2001-02-28
WO1999029662A2 (de) 1999-06-17
CZ20002150A3 (cs) 2001-11-14
EP1045832B1 (de) 2005-03-23
NZ505594A (en) 2001-11-30
CO5290251A1 (es) 2003-06-27
AU747173B2 (en) 2002-05-09
PE133599A1 (es) 2000-01-13
BG104501A (bg) 2001-03-30
EA200000633A1 (ru) 2000-12-25
HUP0100292A2 (hu) 2001-07-30
BR9813545A (pt) 2000-10-10
DE19754795A1 (de) 1999-06-17
SK8602000A3 (en) 2000-11-07
US20020019536A1 (en) 2002-02-14
NO20002968D0 (no) 2000-06-09
KR20010024708A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
BR0010555A (pt) Inibidores de neuraminidases
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
ES2032899T3 (es) Agente cosmetico para aplicacion externa y su uso.
CO4810373A1 (es) Compuestos azapoliciclicos condensados con arilo
BR0207726A (pt) Sais farmacêuticos
ES2196377T3 (es) Derivados de naftiridina.
GT200000037A (es) Procedimientos e intermedios para preparar compuestos anticancerosos.
BR0314577A (pt) Derivados de triazol como inibidores do fator de crescimento de transformação (tgf)
AR023401A1 (es) Derivados de 1,4-benzotiazepina-1,1-dioxido sustituidos con restos de azucar, procedimientos para su preparacion, medicamentos que contienen estoscompuestos, y su empleo para preparar un medicamento
BR0312695A (pt) Derivados de 1h-pirrolidina-2,4-diona espirocìclicos substituìdos por cis-alcóxi
UY27092A1 (es) Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen
GT199900131A (es) Derivados del acido hidroxi-pipecolato hidroxamico.
BR9811988A (pt) Derivados de n-alcanoilfenilalanina
BR0210008A (pt) Derivados de feniluréia substituìdos com carboxamida, processos para produção dos mesmos como medicamentos
BR9804582A (pt) Derivados de ácido benzoazepinona-n-acético substituìdos por açidos fosfÈnicos, assim, como processos para sua preparação e medicamentos que contêm estes compostos.
UY26513A1 (es) Nuevas piperidinas sustituidas, medicamentos que contienen estos compuestos y procedimiento para su preparación.
BR9916422A (pt) Saponinas antiprotozoárias
AR018246A1 (es) Compuestos inositil-glicanos con actividad del tipo de la insulina, procedimiento para su preparacion, composicion farmaceutica que los contiene, procedimiento para la preparacion de dicha composicion farmaceutica, y el uso de dichos compuestos para la preparacion de un medicamento
BR0210285A (pt) Utilização de um composto, composto e composição farmacêutica
ES2175155T3 (es) Cetoacidos aromaticos y sus derivados como inhibidores de las metaloproteinasas matriciales.
UY26501A1 (es) Derivados de piperazina sustituidos, su preparación y su empleo como medicamentos
UY25288A1 (es) Nuevos uretanos, sus análogos tio y ditio, sus sales, medicamentos que contienen estos compuestos y su empleo así como procedimientos para su preparación.
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
AR027050A1 (es) Bencimidazoles, su preparacion y su empleo como medicamentos
AR033779A1 (es) Compuestos utiles en la enfermedad de reflujo

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20071105